🥤 OLIPOP: The $400M+ Prebiotic Soda Quietly Reshaping CPG
Founded: 2018 | HQ: Oakland, CA | Founders: Ben Cowan-Dewar & David Lester
Total Raised: ~$75M | Investors: Prelude Ventures, Monogram Capital + celebrity angels (Camila Cabello, Mindy Kaling, Nick Kroll)
📖 The Story
Olipop didn't invent functional soda — but it perfected the pitch. Built on a proprietary prebiotic fiber blend (OLISMART) targeting gut microbiome health, Olipop became the guilt-free Coke alternative at a moment when consumers were obsessed with wellness and fed up with legacy brands.
The result: from $4M in revenue in 2020 to an estimated $400M+ by 2024. That's 100x growth in four years inside one of the most brutally competitive shelves in retail.
⚙️ Why It Works
The Category Moment — Gut health exploded. Ozempic pulled soda volume down. Consumers wanted something that tasted like a treat but acted like a supplement. Olipop nails that intersection.
Retail-First Distribution — While DTC brands burned cash on Facebook ads, Olipop went deep on Whole Foods, Target, Kroger, and Walmart. Now in 40,000+ doors. That's a real moat.
Flavor + Branding Excellence — Vintage Cola, Classic Root Beer, Cherry Vanilla. Low sugar (2-5g), high fiber (9g per can), actual taste. A rare trifecta.
Capital Efficiency — ~$75M raised to hit $400M+ revenue. Extraordinary for CPG. Most brands blow $200M+ chasing the same outcome.
🥊 The Competitive Heat
Poppi — the direct rival — was acquired by PepsiCo for $1.65B in early 2025. That's the loudest possible signal: Big Soda is terrified and would rather buy than fight. Olipop is now the last major independent in the category — making it either the next acquisition target (Coca-Cola? Keurig Dr Pepper?) or a legitimate IPO story.
📈 The Bull Case for Investors
Poppi's $1.65B exit sets the floor — and Olipop has more revenue
Functional beverage is a $30B+ global category growing at 8% CAGR
No dominant winner yet in prebiotic soda internationally — massive white space in EU & APAC
Gross margins expanding as manufacturing scale hits
Every CPG giant needs a functional beverage platform. Olipop is the cleanest asset available.
⚠️ The Risk
Brand fatigue is real — wellness soda is crowding fast (Poppi, Mayawell, Culture Pop, Sunwink). Distribution wars are expensive. At this scale, the next exit needs to pencil at $1.5B+, requiring continued hyper-growth.
📌 Bottom Line
Olipop is the most compelling remaining CPG unicorn in the prebiotic space. Watch for an IPO filing or strategic acquisition within the next 12-18 months. The checkbooks in Atlanta and Purchase, NY are already open.
